文献速递慢性肾脏病血液净化与透析

晚期CKD患者脂肪miR-130b与miR-17-5p表达与消瘦、心血管事件及死亡的关系

Adipose expression of miR-130b and miR-17-5p with wasting, cardiovascular event and mortality in advanced chronic kidney disease patients.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

单中心前瞻性队列研究纳入拟行腹膜透析的晚期CKD患者,检测皮下及腹膜前脂肪组织miR-130b与miR-17-5p表达,分析其与体成分、衰弱、2年生存及心血管事件的关系。结果显示两miRNA与肌肉量参数相关,miR-130b预测衰弱和MACE,miR-17-5p预测2年全因生存和技术生存。

要点

  • 脂肪miR-130b与miR-17-5p表达与肌肉量参数相关。
  • miR-130b表达可预测衰弱及MACE发生率。
  • miR-17-5p表达可预测2年全因生存和技术生存。

核心结论

  • 脂肪miR-130b和miR-17-5p表达与体成分参数、衰弱相关,并可预测晚期CKD患者心血管事件和死亡。

研究设计与样本

  • 单中心前瞻性队列研究,纳入拟行腹膜透析的晚期CKD患者,于腹膜透析置管时获取皮下和腹膜前脂肪组织检测miRNA表达。

主要发现

  • miR-130b与细胞内水相关(r=0.191,P=0.02),miR-17-5p与细胞内水相关(r=0.211,P=0.013)。
  • miR-17-5p与瘦组织量相关(r=0.176,P=0.04;r=0.176,P=0.004)。
  • miR-130b表达显著预测衰弱(P=0.017)。
  • miR-17-5p表达预测2年全因生存(P=0.020)和技术生存(P=0.036)。
  • miR-130b表达预测MACE发生率(P=0.015)。

临床怎么用

  • 在晚期CKD拟透析患者中,脂肪miRNA表达或可作为评估体成分、衰弱及心血管预后的候选生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data on the association of adipose microRNA expression with body composition and adverse clinical outcomes in patients with advanced chronic kidney disease (CKD). We aimed to evaluate the association of adipose miR-130b and miR-17-5p expressions with body composition, functional state, cardiovascular outcome and mortality in incident dialysis patients. METHODS: We performed a single-center prospective cohort study. Patients who were planned for peritoneal dialysis were recruited. miR-130b and miR-17-5p expressions were measured from subcutaneous and pre-peritoneal fat tissue obtained during peritoneal dialysis catheter insertion. Body composition and physical function were assessed by bioimpedance spectroscopy and Clinical Frailty Scale. Primary outcome was 2-year survival. Secondary outcomes were 2-year technique survival and major adverse cardiovascular event (MACE) rate. RESULTS: Adipose expression of miR-130b and miR-17-5p correlated with parameters of muscle mass including intracellular water (miR-130b: r = 0.191, P = 0.02; miR-17-5p: r = 0.211, P = 0.013) and lean tissue mass (miR-17-5p: r = 0.176, P = 0.04; miR-17-5p: r = 0.176, P = 0.004). miR-130b expression predicted frailty significantly (P = 0.017). Adipose miR-17-5p expression predicted 2-year all-cause survival (P = 0.020) and technique survival (P = 0.036), while miR-130b expression predicted incidence of MACE (P = 0.015). CONCLUSIONS: Adipose miR-130b and miR-17-5p expressions correlated with body composition parameters, frailty, and predicted cardiovascular events and mortality in advanced CKD patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Chan GC, Than WH, Kwan BC, et al. Adipose expression of miR-130b and miR-17-5p with wasting, cardiovascular event and mortality in advanced chronic kidney disease patients. Nephrol Dial Transplant. 2022. PMID: 34601609. doi:10.1093/ndt/gfab287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。